SS Innovations International, Inc.

SSII

US05453U2033

Biotechnology & Medical Research

Delayed OTC Markets Other stock markets 10:35:25 23/05/2024 pm IST			5-day change	1st Jan Change
4.15 ^USD	-2.12%		+14.29%	-44.83%

15/05	SS Innovations International, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
29/04	SS Innovations International, Inc. Achieves Pediatric Milestone with First Infant Pyeloplasty Using SSi Mantra Surgical Robotic System	CI

AVRA Medical Robotics, Inc. Announces the Resignation of Alexandre S. Clug as Vice President of Global Business Development

July 27, 2018 at 11:11 pm IST

Effective July 24, 2018, Alexandre S. Clug resigned as the AVRA Medical Robotics, Inc.'s Vice President of Global Business Development.

Latest news about SS Innovations International, Inc.

SS Innovations International, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05	CI
SS Innovations International, Inc. Achieves Pediatric Milestone with First Infant Pyeloplasty Using SSi Mantra Surgical Robotic System	29/04	CI
SS Innovations International, Inc.?s SSi Mantra Surgical Robotic Device Successfully Completes Telesurgery Procedures	10/04	CI
SS Innovations International, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	23/03	CI
SS Innovations? SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement	12/03	CI
SS Innovations International, Inc. announced that it has received $1 million in funding from Sushruta Pvt. Ltd	14/02	CI
Ss Innovations International, Inc. Announces Filing of Pre-Submission Application to the Center for Devices and Radiological Health of the United States Food and Drug Administration	26/01	CI
SS Innovations International, Inc. Announces Strategic Partnership with Surgical Lab for Distribution in Africa	26/12	CI
SS Innovations International, Inc. Announces Successful Completion of 500 Robotic Surgery Using the Company's Innovative SSi Mantra Surgical Robotic System	27/11	CI
SS Innovations International, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11	CI
SS Innovations International, Inc. Appoints Sonia Shokeen as Head of Quality and Regulatory Affairs	30/23/30	CI
SS Innovations Enters Licensing Agreement with Johns Hopkins University	16/23/16	CI
SS Innovations International, Inc. Appoints Colin Eke to Lead Global Business Development	06/23/06	CI
SS Innovations International, Inc. Launches Innovative Robotic Cardiac Surgery Program in India	03/23/03	CI
SS Innovations International, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	08/23/08	CI
SS Innovations International, Inc. Announces Board Appointments	07/23/07	CI
Government Institution Adopts SS Innovations International, Inc.'s SSi Mantra Surgical Robotic System	30/23/30	CI
SS Innovations International, Inc. Auditor Raises 'Going Concern' Doubt	26/23/26	CI
CardioVentures, Inc. (SSI-DE) completed the acquisition of AVRA Medical Robotics, Inc. for $10.9 million in a reverse merger transaction.	14/23/14	CI
AVRA Medical Robotics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	31/23/31	CI
AVRA Medical Robotics, Inc. Auditor Raises 'Going Concern' Doubt	31/23/31	CI
AVRA Medical Robotics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	01/22/01	CI
AVRA Medical Robotics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	01/22/01	CI
CardioVentures, Inc. (SSI-DE) entered into non-binding letter of intent to acquire AVRA Medical Robotics, Inc. in a reverse merger transaction.	07/22/07	CI
AVRA Medical Robotics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	04/22/04	CI

Chart SS Innovations International, Inc.

Duration

Period

Chart SS Innovations International, Inc.

More charts

SS Innovations International, Inc. is a developer of surgical robotic technologies. The Company is developing a fully autonomous medical robotic system using software, which integrates artificial intelligence (AI) and deep learning, or machine learning (DL). Its product range includes its SSI Mantra surgical robotic system, and SSI Mudra is its range of surgical instruments capable of supporting a variety of surgical procedures, including robotic cardiac surgery. Its instruments under development include NADI-Automated Coronary Anastomotic Connector, SSi Multi-Fire Clip Applier, SSi Ultrasonic Surgical Device, SSi Maya-XR Pre-Operative Simulator, SSi Holographic Anatomy, SSi Yog-Tele Proctor, SSi Chitrasa-Advanced DICOM Viewer and SSi Mixed Reality Headset. The SSi Mantra is comprised of vision cart, which provides an additional 32-inch 3D 4K resolution monitor, identical to the surgeonâs console, for the operating room staff.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
SS INNOVATIONS INTERNATIONAL, INC.	-44.83%	72Cr
MODERNA, INC.	+63.99%	6.26TCr
IQVIA HOLDINGS INC.	-1.32%	4.12TCr
LONZA GROUP AG	+44.76%	4.03TCr
CELLTRION, INC.	-8.93%	2.79TCr
ICON PUBLIC LIMITED COMPANY	+13.40%	2.62TCr
ALNYLAM PHARMACEUTICALS, INC.	-21.84%	1.91TCr
BIO-TECHNE CORPORATION	+4.98%	1.31TCr
UNITED THERAPEUTICS CORPORATION	+25.22%	1.23TCr
MEDPACE HOLDINGS, INC.	+28.21%	1.21TCr